108 related articles for article (PubMed ID: 19292067)
1. [Pharmacokinetics of PEG recombinant human interleukin-6 in rats].
He XL; Yang G; Yin HL; Zhang XM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):149-52. PubMed ID: 19292067
[TBL] [Abstract][Full Text] [Related]
2. A multiple-dose pharmacokinetics of polyethylene glycol recombinant human interleukin-6 (PEG-rhIL-6) in rats.
He XL; Yin HL; Wu J; Zhang K; Liu Y; Yuan T; Rao HL; Li L; Yang G; Zhang XM
J Zhejiang Univ Sci B; 2011 Jan; 12(1):32-9. PubMed ID: 21194184
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of rhGH decorated by polyethylene glycol in rat in vivo].
Jiang L; Cai YM; Zeng Y; Huang J; Chen ZM
Yao Xue Xue Bao; 2009 May; 44(5):506-9. PubMed ID: 19618727
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats.
Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S
Eur J Drug Metab Pharmacokinet; 1998; 23(3):403-10. PubMed ID: 9842984
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction.
Baumann A; Piel I; Hucke F; Sandmann S; Hetzel T; Schwarz T
Eur J Pharm Sci; 2019 Mar; 130():11-20. PubMed ID: 30654111
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs.
Cai Y; Zhang Z; Fan K; Zhang J; Shen W; Li M; Si D; Luo H; Zeng Y; Fu P; Liu C
Regul Pept; 2012 Jan; 173(1-3):74-81. PubMed ID: 21985916
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the absolute bioavailability of pegylated interferon alfa-2a after subcutaneous administration to healthy male volunteers: an open-label, randomized, parallel-group study.
Brennan BJ; Xu ZX; Grippo JF
Clin Ther; 2012 Sep; 34(9):1883-91. PubMed ID: 22858176
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and Pharmacodynamic Evaluation of Different PEGylated Human Interleukin-11 Preparations in Animal Models.
Yu KM; Yiu-Nam Lau J; Fok M; Yeung YK; Fok SP; Hu TL; Tsai YJ; Choo QL
J Pharm Sci; 2018 Nov; 107(11):2755-2763. PubMed ID: 30005986
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of [125I]-recombinant human interleukin-11: 2. Placental transfer and excretion into milk after subcutaneous administration to rats.
Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S
Eur J Drug Metab Pharmacokinet; 1998; 23(3):411-6. PubMed ID: 9842985
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of PEGylated recombinant human endostatin (M2ES) in rats.
Li ZG; Jia L; Guo LF; Yu M; Sun X; Nie W; Fu Y; Rao CM; Wang JZ; Luo YZ
Acta Pharmacol Sin; 2015 Jul; 36(7):847-54. PubMed ID: 26027657
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, tissue distribution and excretion of 40kDa PEG and PEGylated rFVIII (N8-GP) in rats.
Bjørnsdottir I; Sternebring O; Kappers WA; Selvig H; Kornø HT; Kristensen JB; Bagger MA
Eur J Pharm Sci; 2016 May; 87():58-68. PubMed ID: 26517963
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic analysis of pegylated megakaryocyte growth and development factor in humans.
De Boer RH; Roskos LK; Cheung E; Fox S; Basser RL; Marty J; Begley CG; Cebon J
Growth Factors; 2000; 18(3):215-26. PubMed ID: 11334057
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis.
Nemirovskiy O; Zheng YJ; Tung D; Korniski B; Settle S; Skepner A; Yates M; Aggarwal P; Sunyer T; Aguiar DJ
Xenobiotica; 2010 Aug; 40(8):586-92. PubMed ID: 20509748
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of pegylated human erythropoietin in rats.
Jolling K; Ruixo JJ; Hemeryck A; Piotrovskij V; Greway T
J Pharm Sci; 2004 Dec; 93(12):3027-38. PubMed ID: 15503315
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic disposition of polyethylene glycol-modified salmon calcitonins in rats.
Yoo SD; Jun H; Shin BS; Lee HS; Park MO; Deluca PP; Lee KC
Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1921-4. PubMed ID: 11145145
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, tissue distribution, excretion, and metabolite profiling of PEGylated rFIX (nonacog beta pegol, N9-GP) in rats.
Sternebring O; Christensen JK; Bjørnsdottir I
Eur J Pharm Sci; 2016 Sep; 92():163-72. PubMed ID: 27378188
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjects.
Aoyama K; Uchida T; Takanuki F; Usui T; Watanabe T; Higuchi S; Toyoki T; Mizoguchi H
Br J Clin Pharmacol; 1997 Jun; 43(6):571-8. PubMed ID: 9205816
[TBL] [Abstract][Full Text] [Related]
19. Disposition of Basal Insulin Peglispro Compared with 20-kDa Polyethylene Glycol in Rats Following a Single Intravenous or Subcutaneous Dose.
Knadler MP; Ellis BB; Brown-Augsburger PL; Murphy AT; Martin JA; Wroblewski VJ
Drug Metab Dispos; 2015 Oct; 43(10):1477-83. PubMed ID: 26175543
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys.
Yu KM; Lau JY; Fok M; Yeung YK; Fok SP; Zhang S; Ye P; Zhang K; Li X; Li J; Xu Q; Wong WT; Choo QL
Toxicol Appl Pharmacol; 2018 Mar; 342():39-49. PubMed ID: 29407773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
